Pharmaceutical manufacturers of Tolterodine tartrate

Unichem Laboratories was founded in 1944 by Late Mr. Amrut Mody, a pioneer in the Indian pharmaceuticals business. With a rich tradition of unwavering quality and reliability, Unichem brings together a unique blend of modern, value-added research and deep knowledge of the Indian pharmaceuticals industry.ç

Emcure Pharmaceuticals is driven by the purpose to develop, manufacture and market a broad range of pharmaceutical products globally. Our core strength and competitive advantage lie in our established presence in all major therapeutic areas including Gynaecology, cardiology, blood-related, oncology, respiratory, CNS & HIV among others. Emcure has launched 6 Biologics in the Domestic Market & RoW markets & they are the domestic leader in three biologics. With 350+ brands, five R&D centers and 13 manufacturing facilities established across the country, we have ensured a strong presence not just in India but also outside India with a wide network across 70+ countries. Our API facilities ensures that our supply chain is vertically integrated providing flexibility over control of manufacturing. We have cemented strategic global partnerships that are a result of alliances with local and multi-national companies which are at the helm of leadership in key therapeutic areas. The key objective of our widespread presence across markets is to constantly innovate and deliver affordable & high-quality healthcare solutions to people.

Polpharma Group serves as a top-tier pharmaceutical manufacturer in Europe and a reliable partner for pharmaceutical firms globally. With a wide range of products (Rx, CHC, APIs), expert services, and competencies across the value chain, along with extensive knowledge of local CEE/CIS markets, it provides distinct growth opportunities for B2B partners. Collaborating with Polpharma Group offers access to a supportive environment, guidance from skilled professionals, and cutting-edge resources. The company actively seeks partners across various areas of operation, from product development and production to commercial cooperation. Additionally, Polpharma API, a Poland-based CDMO specializing in active pharmaceutical ingredients (APIs), stands as a significant European API supplier, catering to pharmaceutical companies worldwide. The company is in the process of a $45 million manufacturing expansion, incorporating HPAPI and cryogenic technologies, with investments in a pilot plant and R&D capabilities. Operations are set to expand from mid-2023, with full completion expected by 2026.

Polepharma has been organizing and advancing the pharmaceutical industry in France, specializing in the biopharmaceutical sector for two decades. It has developed into the leading European hub for drug production, facilitating collaboration between excellence centers and industry stakeholders. Polepharma is committed to three collective principles, including the bold ambition to position France as the global leader in pharmaceutical development. On the other hand, Polpharma is a prominent CDMO and API producer based in Poland. With over 70 years of expertise, it stands as the largest API manufacturer in Poland, offering a comprehensive range of materials from clinical quantities to market supply. The company has fully integrated its operations, covering R&D to manufacturing, to provide cost-effective and timely solutions to its clients. Furthermore, Polpharma has made significant investments to enhance its API plant in Starogard Gdanski, incorporating HPAPI and cryogenic technologies, along with a pilot plant and R&D capabilities.

Bringing 86 years of expertise, UQUIFA'S operational approach is built on a fusion of a high-quality production platform and a proven history of service and dependability. UQUIFA specializes in the production of Active Pharmaceutical Ingredients (APIs), Intermediates, and RSM's for the pharmaceutical and animal health sectors on a global scale. The organization runs 2 production facilities (located in Spain and Mexico) with stringent compliance to all regulatory standards. These facilities operate under cGMP conditions and have undergone evaluation and endorsement from prominent global pharmaceutical companies.

Erregierre, with its two manufacturing facilities, one situated in San Paolo D'Argon (Bergamo) and the other in Sovere (Bergamo), is a privately owned independent company from Italy established in 1974. It is a leading producer of pharmaceutical active components created through synthesis and distributed globally. Erregierre has undergone inspection by the FDA and is deeply dedicated to manufacturing in strict compliance with cGMPs and the highest global quality standards.

Maithri Drugs stands as one of the rapidly emerging pharmaceutical firms in India. Maithri's primary emphasis is on active pharmaceutical ingredients (APIs). The corporation is widely acknowledged for its exceptional research & development and ambitious expansion approaches. Our 125+Global DMFs, including 50 in the United States and 22 in the EU within a brief duration, bear witness to our R&D superiority. Maithri's production site is situated in Hyderabad. This site is scrutinized and endorsed by the US FDA. Furthermore, our facility is accredited in accordance with the criteria of DCGI, WHO GMP, and ISO 9001.

A company from Mexico with over 40 years of experience in the industry. Megafarma distributes API for the pharmaceutical market (human and veterinary), as well as for the food market, diagnostics, pets market, nutraceuticals, and phytoterapy companies - top manufacturers worldwide. Our goals include continual diversification and ensuring customer satisfaction. We play a pivotal role in the advancement of the pharmaceutical sector.

Zim offers innovative solutions for administering medications, focusing on enhancing patient convenience and compliance. The company utilizes its own advanced technologies, such as modified release and taste masking, to create and produce distinct pharmaceutical products. Their range includes oral solid dosage formulations and pre-formulations (PFI), encompassing tablets, capsules, dry syrups, pellets, granules, and orally disintegrating strips (ODS). Additionally, they provide services for site transfer/variation for sustained release tablets, oral disintegrating tablets, fast disintegrating capsules, and more.

A trusted Indian pharmaceutical company with strong people and technology capabilities, providing affordable, high-quality products that meet the healthcare needs of people across the globe.

Bal Pharma is a leading Indian Pharmaceutical Company with 32+years’ of experience, specialized in Prescription Drugs, Generic medicines & OTC Products, Intravenous Infusion and Bulk Actives. We strive hard to improve the quality of life for patients by providing them products that are Safe, Effective, High Quality and Affordable. Bal Pharma’s API and FDF are produced at world class manufacturing facilities. Our APIs are largely exported to Europe, Far East, Latin America, Africa, Middle East and other World markets. The FDF are exported to Semi-Regulated, Non-Regulated market and are now foraying to regulated market. We are also one of the strong contenders for World Tender Business.

Maithili Life Sciences offers services including DMF, CEP, Written Confirmations, FDF, Prices, Patents, Patents & Exclusivities, Dossier, Manufacturer, Licensing, Distributer, Suppliers, and News related to GMP.

Shodhana Laboratories, a company with certifications including WHO GMP, ISO 9001-2008, and ISO 14000:2004, is renowned as one of the most vibrant manufacturers of Active Pharmaceutical Ingredients and Intermediates. At present, the company boasts cutting-edge production facilities and adheres to ICH & cGMP guidelines throughout the manufacturing process. Furthermore, it houses a first-rate R&D lab staffed by a team of highly qualified and experienced scientists.

Torbay Pharmaceuticals specializes in the exploration, production, manufacturing, and promotion of injectable, terminally sterilized generic medicinal products for specialized medical care. The company serves as a CDMO/CMO for some of the leading global pharmaceutical firms, prominently present in the North American market. In addition to this, Torbay possesses a diverse array of injectable products, both licensed and unlicensed, and is seeking partnerships in Europe and beyond for the distribution and promotion of these products. The primary areas of emphasis for Torbay include the continual expansion of the CDMO/CMO business and the licensing and out-licensing of their current and upcoming line of injectable medications.. Tooba Pharmaceuticals Private Limited (TPPL) is a GMP Certified manufacturer of API Bulk Drugs and Intermediates, with a cutting-edge manufacturing facility. TPPL maintains its firm commitment to research and development for the exploration and development of generic drugs utilizing innovative technologies in an environmentally conscious manner. TPPL is headquartered in Aurangabad, Maharashtra, a prominent urban center and industrial focal point housing numerous pharmaceutical industries. Well-linked to major metropolitan areas within the state and beyond, it offers convenient access to markets and raw materials.